262
Views
53
CrossRef citations to date
0
Altmetric
Original Research

Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration

, , , , , , & show all
Pages 8309-8323 | Published online: 06 Dec 2018

References

  • BertuccioPTuratiFCarioliGGlobal trends and predictions in hepatocellular carcinoma mortalityJ Hepatol201767230230928336466
  • JemalACenterMMDesantisCWardEMGlobal patterns of cancer incidence and mortality rates and trendsCancer Epidemiol Biomarkers Prev20101981893190720647400
  • SiegelRLMillerKDJemalAColorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970–2014JAMA2017318657257428787497
  • BruixJReigMShermanMEvidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular CarcinomaGastroenterology2016150483585326795574
  • ParkJWChenMColomboMGlobal patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyLiver Int20153592155216625752327
  • RazaASoodGKHepatocellular carcinoma review: current treatment, and evidence-based medicineWorld J Gastroenterol201420154115412724764650
  • DuttaRMahatoRIRecent advances in hepatocellular carcinoma therapyPharmacol Ther201717310611728174094
  • WaidmannOTrojanJNovel drugs in clinical development for hepatocellular carcinomaExpert Opin Investig Drugs201524810751082
  • D’SouzaAADevarajanPVAsialoglycoprotein receptor mediated hepatocyte targeting – strategies and applicationsJ Control Release201520312613925701309
  • TuratoCBalassoACarloniVNew molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinomaJ Control Release201726818419729051062
  • FuLSunCYanLGalactose targeted pH-responsive copolymer conjugated with near infrared fluorescence probe for imaging of intelligent drug deliveryACS Appl Mater Interfaces2015732104211525569169
  • SinghBJangYMaharjanSCombination therapy with doxorubicin-loaded galactosylated poly(ethyleneglycol)-lithocholic acid to suppress the tumor growth in an orthotopic mouse model of liver cancerBiomaterials201711613014427914985
  • NelsonKMDahlinJLBissonJGrahamJPauliGFWaltersMAThe Essential Medicinal Chemistry of CurcuminJ Med Chem20176051620163728074653
  • KunnumakkaraABBordoloiDPadmavathiGCurcumin, the golden nutraceutical: multitargeting for multiple chronic diseasesBr J Pharmacol2017174111325134827638428
  • VallianouNGEvangelopoulosASchizasNKazazisCPotential anticancer properties and mechanisms of action of curcuminAnticancer Res201535264565125667441
  • Bar-SelaGEpelbaumRSchafferMCurcumin as an anti-cancer agent: review of the gap between basic and clinical applicationsCurr Med Chem201017319019720214562
  • YuZYuMZhangZHongGXiongQBovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner earNanoscale Res Lett20149134325114637
  • FabiAGiannarelliDMalagutiPProspective study on nanoparticle albumin-bound paclitaxel in advanced breast cancer: clinical results and biological observations in taxane-pretreated patientsDrug Des Devel Ther2015961776183
  • NosratiHSefidiNSharafiADanafarHKheiri ManjiliHManjiliHKAlbuminBSBovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drugBioorg Chem20187650150929310081
  • FuCDingCSunXFuACurcumin nanocapsules stabilized by bovine serum albumin-capped gold nanoclusters (BSA-AuNCs) for drug delivery and theranosisMater Sci Eng C Mater Biol Appl20188714915429549944
  • FuLSunYDingLMechanism evaluation of the interactions between flavonoids and bovine serum albumin based on multi-spectroscopy, molecular docking and Q-TOF HR-MS analysesFood Chem201620315015726948600
  • LeeWHLooCYYoungPMTrainiDMasonRSRohanizadehRRecent advances in curcumin nanoformulation for cancer therapyExpert Opin Drug Deliv20141181183120124857605
  • StowellCPLeeVCNeoglycoproteins: the preparation and application of synthetic glycoproteinsAdv Carbohydr Chem Biochem1980372252816996450
  • WaCCernyRLClarkeWAHageDSCharacterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometryClin Chim Acta20073851–2486017707360
  • LiuJJingHGlycation of bovine serum albumin with monosaccha-rides inhibits heat-induced protein aggregationRSC Adv20166116115183115188
  • WeberKOsbornMThe reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresisJ Biol Chem196924416440644125806584
  • LaemmliUKCleavage of structural proteins during the assembly of the head of bacteriophage T4Nature197022752596806855432063
  • LangerKBalthasarSVogelVDinauerNvon BriesenHSchubertDOptimization of the preparation process for human serum albumin (HSA) nanoparticlesInt J Pharm20032571–216918012711172
  • LiJChenTDengFSynthesis, characterization, and in vitro evaluation of curcumin-loaded albumin nanoparticles surface-functionalized with glycyrrhetinic acidInt J Nanomedicine2015105475548726346750
  • WeberCKreuterJLangerKDesolvation process and surface characteristics of HSA-nanoparticlesInt J Pharm2000196219720010699717
  • HirayamaKAkashiSFuruyaMFukuharaKRapid confirmation and revision of the primary structure of bovine serum albumin by ESIMS and Frit-FAB LC/MSBiochem Biophys Res Commun199017326396462260975
  • JingHKittsDDChemical characterization of different sugar-casein Maillard reaction products and protective effects on chemical-induced cytotoxicity of Caco-2 cellsFood Chem Toxicol200442111833184415350681
  • KawakamiSHashidaMGlycosylation-mediated targeting of carriersJ Control Release201419054255524915504
  • NishikawaMMiyazakiCYamashitaFTakakuraYHashidaMGalactosylated proteins are recognized by the liver according to the surface density of galactose moietiesAm J Physiol19952685 Pt 1G849G8567762669
  • LiCZhangDGuoHPreparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridoninInt J Pharm20134481798623518367
  • LiJYuSYaoPJiangMLysozyme-dextran core-shell nanogels prepared via a green processLangmuir20082473486349218302424
  • BourassaPKanakisCDTarantilisPPollissiouMGTajmir-RiahiHAResveratrol, genistein, and curcumin bind bovine serum albuminJ Phys Chem B201011493348335420148537
  • YuHNguyenMHCheowWSHadinotoKA new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albuminMater Sci Eng C Mater Biol Appl201775253328415461
  • SalehiabarMNosratiHJavaniEProduction of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin deliveryInt J Biol Macromol2018115838929653171
  • ChanJMZhangLYuetKPPLGA-lecithin-PEG core-shell nanoparticles for controlled drug deliveryBiomaterials20093081627163419111339
  • YeZWuWRQinYFAn integrated therapeutic delivery system for enhanced treatment of hepatocellular carcinomaAdv Funct Mater2018281817066001706613